1-3 of 3
Charles Lopez, MD PhD
Close
Sort by
Journal Articles

Oncogenic Splicing of the Apoptosis-Stimulating Protein of p53-2 ( ASPP2 ) Is an Initiating Step in Leukemogenesis Facilitating Acquisition of Structural Genomic Mutations

Kerstin Maria Kampa-Schittenhelm, MD, Ulrike Mau-Holzmann, Charles Lopez, MD PhD, Marcus M. Schittenhelm
Journal: Blood
Blood (2016) 128 (22): 1555.
https://doi.org/10.1182/blood.V128.22.1555.1555
Published: 2016
Journal Articles

Attenuation of Apoptosis-Stimulating Protein of p53-2 (ASPP2) Promotes IL-3-Independent Growth and Enhances Cytogenetic Abnormalities after Gamma-Irradiation in Mouse Hematopoietic Cells - Mimicking Early Leukemogenesis of Therapy-Associated Human AML

Kerstin Maria Kampa-Schittenhelm, MD, Ulrike Mau-Holzmann, Lothar Kanz, Prof. Dr. MD, Charles Lopez, MD PhD, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2015) 126 (23): 2460.
https://doi.org/10.1182/blood.V126.23.2460.2460
Published: 2015
Journal Articles

Apoptosis Stimulating Protein of p53 (ASPP2) Heterozygous Mice Are Lymphoma-Prone and Display Attenuated Apoptosis and Cell Cycle Checkpoints

Kerstin Maria Kampa, MD, Jared Acoba, MD, Dexi Chen, MD, PhD, Hun-Joo Lee, Kelly Beemer, Joel Gay, Zhyi Zhu, Emerson Padiernos, Marcus M Schittenhelm, MD, Lothar Kanz, MD, Christopher Corless, MD, PhD, Charles Lopez, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2844.
https://doi.org/10.1182/blood.V112.11.2844.2844
Published: 2008